[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Bionavgator KBKB posts on X about $rvmd, $abvx, $cytk, acquisition the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXXX% currencies XXXX%
Social topic influence $rvmd #3, $abvx #39, $cytk #2, acquisition #722, sanofi #11, $bbio 11.11%, $mdgl 11.11%, at least 11.11%, $cogt #14, $tern XXXX%
Top accounts mentioned or mentioned by @seedy19tron @aggregategains @doepkemichel @aaronrosenblum5 @bananaoncology @banana_oncology @40 @trumpokim @doodaddoctor @maximizebelief2 @dwights2025 @jbsteelers36 @houndcl @bigchodu @curioso_et_cie @randombiothinks @craigster771 @streetcred2017
Top assets mentioned Revolution Medicines, Inc. Common Stock (RVMD) Cytokinetics Inc. (CYTK) Sanofi (SNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Cogent Biosciences, Inc. Common Stock (COGT) Terns Pharmaceuticals, Inc. Common Stock (TERN) Janux Therapeutics, Inc. Common Stock (JANX) Vir Biotechnology, Inc. Common Stock (VIR) Arrowhead Research Corporation (ARWR) Johnson & Johnson (JNJ) Protagonist Therapeutics, Inc (PTGX) Eli Lilly and Company (LLY)
Top posts by engagements in the last XX hours
"@seedy19tron Honestly $tern has lots to prove to establish its profile if it beats scemblix from efficacy stand point with clean tox then We can assume blue sky scenarios with 5B revs not there yet. price has to cool down a bit. IMO"
X Link 2025-12-06T00:48Z XXX followers, XXX engagements
"Contrarian trade idea: $janx XX puts are still cheap if the durability data disappoints stock would trade down by a lot these put could fly 3x-5x. There are lots of expectations going into XXX data ran almost XX% on the pre-data PR. If data is positive- you can buy $VIR stock after hours to minimize losses. NFA"
X Link 2025-12-01T17:10Z XXX followers, 4810 engagements
"Now that Evercore confirmed more 15B deals coming some more tickers for buyout predication $arwr - Gilead $asnd - Amgen"
X Link 2025-12-04T19:49Z XXX followers, 8227 engagements
"@seedy19tron Sanofi csl gsk azn and may be jnj use your imagination"
X Link 2025-12-05T23:24Z XXX followers, 1692 engagements
"@seedy19tron @AaronRosenblum5 $rvmd is still affordable until it isn't soon"
X Link 2025-12-06T00:39Z XXX followers, XXX engagements
"Which one of these gets acquired before JPM26 Others specify in the comments"
X Link 2025-12-08T21:47Z XXX followers, XXX engagements
"$abvx $cogt $rvmd $cytk"
X Link 2025-12-08T22:01Z XXX followers, 1021 engagements
"@Banana_Oncology Cant or a stretch to afford Not sure bod will signoff or will be confident to make such large acquisitions given not so great ROI from high profile acqs.25B is 1/4 th of the market cap.too much risk for them"
X Link 2025-12-06T05:23Z XXX followers, XXX engagements
"My prediction before JPM26: At least one more 15B acquisition $cytk - Sanofi $abvx - lilly $RVMD - Merck/Roche $BBIO -AZN $MDGL - NVO"
X Link 2025-12-03T19:37Z XXX followers, 19.9K engagements
"If $abvx gets acquired soon then abbv will be more aggressively looking for combo therapies to protect their empire. $pali would be a good choice as it is gut restricted with no addt'l tox even $jnj needs this strategy even with or without $ptgx acquisition. they both need a small molecule (non-biologic) to combine. $pali is in a good spot either way"
X Link 2025-12-07T02:18Z XXX followers, 4945 engagements
"$rvmd acting like pdac results will be in before Jpm26"
X Link 2025-12-09T17:45Z XXX followers, XXX engagements
"@seedy19tron $lly stock down 10days in a row. just saying.may be market anticipating a big buyout from lilly"
X Link 2025-12-10T02:54Z XXX followers, 1825 engagements